- Home
- A-Z Publications
- Current Pharmaceutical Design
- Previous Issues
- Volume 20, Issue 39, 2014
Current Pharmaceutical Design - Volume 20, Issue 39, 2014
Volume 20, Issue 39, 2014
-
-
oa Editorial (Thematic Issue: Modifying Cardiovascular Risk Factors: Newer Advances in Cardiovascular Metabolism and Diagnostic Technologies)
More LessThe metabolic disorders, both as such and associated with other cardiovascular risk factors, are a group of pathological alterations in the steady expansion with regard to their rate [1]. In addition, a clear adverse interference with the heart and blood vessels has been widely described [2-5]. When other cardiovascular risk factors are associated, cardiovascular damage gets worse exponentially depending also on the type of Read More
-
-
-
Modification of Lifestyle Factors are Needed to Improve the Metabolic Health of Patients with Cardiovascular Disease Risk
More LessCardiovascular risk factors, irregardless of their assessment modalities, are based on cardiovascular health. Lifestyle influences metabolic profiles and these changes affect cardiovascular risk factors. Cardiovascular risk factors can be classified into three basic categories: 1. Predisposing risk factors (e.g., age, gender, medical history, and genetic factors); 2. Clinical and metabolic factors (e.g., hypertension, changes in lipid me Read More
-
-
-
New Insight into Urate-Related Mechanism of Cardiovascular Damage
Authors: Davide Grassi, Giovambattista Desideri and Claudio FerriSeveral experimental and clinical studies reported that hyperuricemia may trigger hypertension, metabolic syndrome, vascular damage and renal disease. Furthermore, a substantial proportion of epidemiological studies are compatible with the hypothesis that hyperuricemia may be an indipendent risk factor for cardiovascular disease as well as for an increased cardiovascular mortality. Xanthine oxidase is a critical sour Read More
-
-
-
Hypertension and Atrial Fibrillation: Any Change with the New Anticoagulants
Authors: Lorenzo Ghiadoni, Stefano Taddei and Agostino VirdisHypertension and atrial fibrillation are the most common cardiovascular risk factors and clinically significant arrhythmia, respectively. These conditions frequently coexist and their prevalence increases rapidly with aging. Despite several different risk factors and clinical conditions predisposing to hypertension for its high prevalence in the population is still the main risk factor for the development of atrial fibrillation. Read More
-
-
-
Treating Arterial Stiffness in Young and Elderly Patients with the Metabolic Syndrome
Authors: Konstantinos Tziomalos, Vasilios G. Athyros and Asterios KaragiannisArterial stiffness is independently associated with increased cardiovascular risk in patients with cardiovascular risk factors and in the general population. Metabolic syndrome (MetS) is frequently characterized by increased arterial stiffness since all components of MetS are implicated in the pathogenesis of arterial stiffness. We review the management of arterial stiffness in patients with MetS. Several small, short-term studie Read More
-
-
-
Psoriasis and Vascular Risk: An Update
Psoriasis is a chronic systemic inflammatory disease characterized by topical skin lesions as well as an increased risk for cardiovascular disease (CVD). There is also increasing evidence that patients with psoriasis are more prone to several CVD risk factors (hypertension, obesity, dyslipidemia and smoking), non-cardiac vascular diseases (carotid, peripheral artery and chronic kidney disease) and metabolic co-morbidities (type Read More
-
-
-
Imaging of Organ Metabolism in Obesity and Diabetes: Treatment Perspectives
Authors: Hannukainen J.C., Guzzardi M.A., Virtanen K.A., Sanguinetti E., Nuutila P. and Iozzo P.Obesity and diabetes are growing threats for cardiovascular diseases (CVD) and heart failure. In order to identify early and effective treatment or prevention targets, it is fundamental to dissect the role of each organ and the sequence of events leading from health to obesity, diabetes and cardiovascular diseases. The advancements in imaging modalities to evaluate organ-specific metabolism in humans in vivo is substantial Read More
-
-
-
Cardiological Ultrasound Imaging
Authors: Johan M. Thijssen and Chris L. de KorteThis review paper is intended for the interested outsider of the field of echocardiography and it presents a short introduction into the numerous ultrasound (US) methods and techniques for anatomical and functional diagnosis of the heart. The basic techniques are generally used for some times already, as there are one dimensional (1D) M(otion) mode, the real time 2D B(rightness) mode technique and the various Doppler Read More
-
-
-
Hyperpolarized Metabolic MR in the Study of Cardiac Function and Disease
Authors: M.H. Lauritzen, L.V. Sogaard, P.L. Madsen and J.H. Ardenkjaer-LarsenSeveral diseases of the heart have been linked to an insufficient ability to generate enough energy (ATP) to sustain proper heart function. Hyperpolarized magnetic resonance (MR) is a novel technique that can visualize and quantify myocardial energy metabolism. Hyperpolarization enhances the MR signal from a biological molecule of interest by more than 10,000 times, making it possible to measure its cellular upta Read More
-
-
-
Models and Methods in Cardiac Imaging for Metabolism Studies
Authors: Santarelli M.F., Martini N., Positano P. and Landini L.Cardiac health depends on the heart’s ability to utilize different substrates to support overall oxidative metabolism. To characterize a variety of cardiac diseases, there is an ever-growing demand for an accurate non-invasive approach to evaluating myocardial substrate metabolism. Data obtained from quantitative metabolic imaging modalities add functional information to the anatomic imaging modalities and can aid pati Read More
-
-
-
SPARC in Tumor Pathophysiology and as a Potential Therapeutic Target
Authors: Jianguo Feng and Liling TangCell migration and metastasis greatly contribute to the progression of tumors. Secreted Protein and Rich in Cysteine SPARC, as a multi-faceted protein, is highly expressed in highly metastatic tumors while low or undetectable in less metastatic types with aberrant promoter methylation. In highly metastatic tumors, such as glioblastomas, melanoma, breast cancer and prostate cancer, SPARC promotes bone metastasis and Read More
-
-
-
The Case for Using Higher Doses of First Line Anti-Tuberculosis Drugs to Optimize Efficacy
Authors: Sylvain Goutelle, Laurent Bourguignon, Pascal Maire, Roger W. Jelliffe and Michael N. NeelyApart from new anti-tuberculosis drug development, another approach for tuberculosis (TB) treatment optimization is to derive maximum benefit from current agents. However, the dosage of current anti-TB drug regimens has never been optimized according to the exposure-effect relationships of each drug. The objective of this article is to review the latest pharmacokinetic, pharmacodynamic, experimental, and cli Read More
-
-
-
Mycobacterium w Immunotherapy for Treating Pulmonary Tuberculosis - a Systematic Review
Authors: Shaheen Pandie, Mark E. Engel, Zita S. Kerbelker and Bongani M. MayosiBackground: Tuberculosis (TB) remains a global health catastrophe. Mycobacterium w is a heat-killed immune-modulating vaccine designed to attenuate the effects of TB, reduce time to sputum conversion, and thereby decrease transmission and improve cure rates. Objectives: To evaluate Mycobacterium w (M w) immunotherapy as an adjunct to chemotherapy in participants with pulmonary TB (PTB). Search strategy: In Jan Read More
-
Volumes & issues
-
Volume 31 (2025)
-
Volume 30 (2024)
-
Volume 29 (2023)
-
Volume 28 (2022)
-
Volume 27 (2021)
-
Volume 26 (2020)
-
Volume 25 (2019)
-
Volume 24 (2018)
-
Volume 23 (2017)
-
Volume 22 (2016)
-
Volume 21 (2015)
-
Volume 20 (2014)
- Issue 42
- Issue 41
- Issue 40
- Issue 39
- Issue 38
- Issue 37
- Issue 36
- Issue 35
- Issue 34
- Issue 33
- Issue 32
- Issue 31
- Issue 30
- Issue 29
- Issue 28
- Issue 27
- Issue 26
- Issue 25
- Issue 18
- Issue 24
- Issue 23
- Issue 22
- Issue 21
- Issue 20
- Issue 19
- Issue 17
- Issue 16
- Issue 15
- Issue 14
- Issue 13
- Issue 12
- Issue 11
- Issue 10
- Issue 9
- Issue 8
- Issue 7
- Issue 6
- Issue 5
- Issue 4
- Issue 3
- Issue 2
- Issue 1
-
Volume 19 (2013)
-
Volume 18 (2012)
-
Volume 17 (2011)
-
Volume 16 (2010)
-
Volume 15 (2009)
-
Volume 14 (2008)
-
Volume 13 (2007)
-
Volume 12 (2006)
-
Volume 11 (2005)
-
Volume 10 (2004)
-
Volume 9 (2003)
-
Volume 8 (2002)
-
Volume 7 (2001)
-
Volume 6 (2000)
Most Read This Month
Article
content/journals/cpd
Journal
10
5
false
en
